Capitalize: The researcher filed 48 patent claims, 25% of which are independent claims. Of the independent claims, 1/3 include novel protein sequences, and 40% of those are approved immediately. How many novel protein sequence claims were approved?
["Capitalize: Key Breakthroughs in Nuclear Protein Research and Patent Milestones", "In a recent milestone, a researcher filed 48 patent claims related to groundbreaking discoveries in novel protein sequences with therapeutic potential. Among these, a carefully structured patent strategy is driving rapid approval and strong innovation recognition.", "Breakdown of Patent Claims:", "- Total patent claims filed: 48\n- Percentage of independent claims: 25%\n- Number of independent claims:\n $ 48 \ imes 0.25 = 12 $ independent claims", "Of these 12 independent claims:\n- 1/3 include novel protein sequences with unique structural and functional properties ($ 12 \div 3 = 4 $ novel protein sequence claims).\n- 40% of these novel protein sequence claims were approved immediately upon filing.\n $ 4 \ imes 0.40 = 1.6 $, which rounds to 1 claim approved immediately (since patent office practices typically approve whole claims).", "Final Result:\nOut of the 48 total claims, 1 novel protein sequence claim was approved immediately. This reflects the high novelty and strategic focus of the researcher’s core innovation portfolio.", "This structured patent approach—emphasizing strong independent claims rich in novelty—highlights the importance of precision in claim drafting for accelerating intellectual property approval and securing competitive advantage in life sciences innovation.", "---", "Keywords: patent claims, independent claims, novel protein sequences, patent approval rate, intellectual property strategy, protein innovation, lifespan patent filings, biotech research."]
